During the company's third quarter earnings call, CEO Mark Casper highlighted a number of recent clinical and diagnostic product launches and initiatives.
Samsung has been awarded US Patent No. 8,618,253, "Modified RNAse H and detection of nucleic acid amplification."
Win Den Chung and Jason Opdyke are named as inventors.
Bio-Rad Laboratories has been awarded US Patent No. 8,560,247, "Multi-stage, regression-based PCR analysis system."
Jeffrey Lerner is named as the inventor.
Russia says its candidate SARS-CoV-2 vaccine has a very high efficacy rate in an initial analysis of clinical trial data, according to the Financial Times.
